Mutation and treatment profiles of patients with concurrent EGFR and ALK actionable mutations (muts).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.3138
Abstract: 3138 Background: Actionable muts in EGFR and ALK define two molecular subtypes sensitive to EGFR-TKIs and ALK-TKIs, respectively. Although generally mutually exclusive, they did co-exist in some cases. However, when and how do they co-exist… read more here.
Keywords: alk muts; alk; egfr tkis; egfr ... See more keywords